학술논문
KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission
Document Type
Article
Author
Kuhen, K.L.; Chatterjee, A.K.; Gagaring, K.; Borboa, R.; Buenviaje, J.; Chen, Z.; Francek, C.; Wu, T.; Nagle, A.; Barnes, S.W.; Plouffe, D.; Taylor, J.; Walker, J.R.; Tully, D.; Winzeler, E.A.; Glynne, R.J.; Rottmann, M.; Lee, M.C.S.; Fidock, D.A.; Graumans, W.; Van De Vegte-Bolmer, M.; Van Gemert, G.J.; Sauerwein, R.W.; Wirjanata, G.; Marfurt, J.; Price, R.N.; Sebayang, B.; Russell, B.; Suwanarusk, R.; Renia, L.; Nosten, F.; Sattabongkot, J.; Tungtaeng, A.; Gettayacamin, M.; Patra, K.P.; Vinetz, J.M.; Flannery, E.L.; Diagana, T.T.
Source
In: Antimicrobial Agents and Chemotherapy . (Antimicrobial Agents and Chemotherapy, September 2014, 58(9):5060-5067)
Subject
Language
English
ISSN
10986596
00664804
00664804